investordatabase.org

Brandon BioCatalyst

brandonbiocatalyst.com Direct investor

Brandon BioCatalyst is a life science investment fund managed by Brandon Capital that invests in early-stage biomedical discoveries originating from its member research organisations in Australia and New Zealand. It provides capital and operational expertise to commercialise new therapies and technologies.

Brandon BioCatalyst is a venture capital firm headquartered in Melbourne, Australia, founded in 2007. It invests directly in companies, at seed, in biomedical, life science, medical therapies and medical technologies. 50 portfolio companies, as it reports.

“We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.”

Brandon BioCatalyst, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed
Headquarters
Melbourne, Australia
Invests in
Australia, New Zealand
Sectors
biomedical, life science, medical therapies, medical technologies
Founded
2007
Portfolio
50 companies

Team, as Brandon BioCatalyst publishes it

  • Hon. Peter Beattie AC Chair
  • Kylie Diwell Director
  • Chris Nave Chief Executive Officer
  • Erica Bremner Kneipp Director
  • Ross King Deputy Chair
  • Sir Michael Daniell Director
  • Maria Wilton, AM Director
  • Hon. Alan Stockdale AO Emeritus Advisor
  • Dr Andrew Nash
  • Bill Ferris, AC Emeritus

Names and roles exactly as listed on brandonbiocatalyst.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Brandon BioCatalyst publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 8097 · added 2026-09-20 · link last verified 2026-09-20 · confidence high

Similar investors

Listed under